CEO and President of Rubius Therapeutics Inc (30-Year Financial, Insider Trades) Pablo J Cagnoni (insider trades) bought 21,000 shares of RUBY on 04/14/2020 at an average price of $4.7 a share. The total cost of this purchase was $98,700.
Rubius Therapeutics Inc has a market cap of $359.920 million; its shares were traded at around $4.48 . GuruFocus has detected 1 severe warning sign with Rubius Therapeutics Inc. .
CEO Recent Trades:
- CEO and President Pablo J Cagnoni bought 21,000 shares of RUBY stock on 04/14/2020 at the average price of $4.7. The price of the stock has decreased by 4.68% since.
Directors and Officers Recent Trades:
- Director David R Epstein bought 5,000 shares of RUBY stock on 03/17/2020 at the average price of $3.76. The price of the stock has increased by 19.15% since.
For the complete insider trading history of RUBY, click here
.